UK cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.7% during the forecast period. The major factor that contribute in the market growth include increasing CVDs in the country coupled with availability of advanced diagnostic technology for heart related diseases in the country. Furthermore, the nation has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease. According to one of the reports published by British Heart Foundation in 2017, more than one-fourth of the fatalities in UK are due to CVD, which is responsible for around 1.6 million fatalities each year. Moreover, growing preference towards personalized medicine further provide substantial opportunity to the market.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/uk-cardiac-biomarker-market
The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the UK cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/uk-cardiac-biomarker-market
The companies which are contributing to the growth of UK cardiac biomarker market include Abbott Laboratories, BioMérieux S.A., Cisbio Bioassays SAS, Danaher Corp., F. Hoffmann-La Roche AG, HyTest Ltd, Merck KGaA, and others. The market players are considerably contributing to the market growth by the adoption of varioUK strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Market Segmentation
UK Cardiac Biomarker Market by Type
- Creatine kinase (CK-MB)
- Troponins(T,I)
- Myoglobin
- Natriuretic peptides (BNP & NT-PROBNP)
- Ischemia modified albumin
- Others
UK Cardiac Biomarker Market by Application
- Myocardial infraction
- Congestive heart failure
- Acute coronary syndrome
- Atherosclerosis
- Others
UK Cardiac Biomarker Market by Location of Testing
- Laboratory testing
- Point of care testing
Company Profiles
- Abbott Laboratories
- BioMérieux S.A.
- Cisbio Bioassays SAS
- Danaher Corp.
- Hoffmann-La Roche AG
- HyTest Ltd
- Merck KGaA
- Randox Laboratories Ltd.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
